Provided by Tiger Trade Technology Pte. Ltd.

ImmunityBio, Inc.

7.72
-0.3400-4.22%
Post-market: 7.720.00000.00%16:33 EDT
Volume:8.79M
Turnover:68.03M
Market Cap:8.18B
PE:-7.81
High:7.89
Open:7.87
Low:7.64
Close:8.06
52wk High:12.43
52wk Low:1.95
Shares:1.06B
Float Shares:407.00M
Volume Ratio:1.29
T/O Rate:2.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9887
EPS(LYR):-0.3820
ROE:78.05%
ROA:-30.54%
PB:-7.82
PE(LYR):-20.21

Loading ...

Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 25, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Feb 24, 2021

Major Issues Report

8-K - Current report
Feb 24, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Feb 10, 2021

Major Issues Report

8-K - Current report
Jan 13, 2021

Major Issues Report

8-K - Current report
Jan 13, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Dec 22, 2020

Major Issues Report

8-K - Current report
Dec 22, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Dec 22, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Dec 21, 2020

Major Issues Report

8-K - Current report
Dec 21, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Dec 21, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 21, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Dec 21, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Nov 09, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 26, 2020

Major Issues Report

8-K - Current report
Aug 24, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 07, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]